How to understand the suitable indications and threshods used in the continuous reassessment of the benefit-risk analysis and of the risk management as defined in Annex III section 1.1(b) point 3 of MDR?
There are some examples and some basic introduction of the frame of the PMS plan in the ISO/TR 20416:2020(E). However, I haven't found any information about the suitable indications and threshods required in the content of the PMS plan. How and why?
Any comment could be appreciated!
There are some examples and some basic introduction of the frame of the PMS plan in the ISO/TR 20416:2020(E). However, I haven't found any information about the suitable indications and threshods required in the content of the PMS plan. How and why?
Any comment could be appreciated!